Please note that presentations will be added as we receive them. This list may not include all presentations and that speakers may update their presentations onsite at the conference.

Conference Recording
Passcode: J2&tC4W8

Additional Resources to Supplement Your Learning

• Cancer Types
  Education and resources to help multidisciplinary cancer care teams stay abreast of disease-specific advances, deploy strategies for effective integration into practice, and engage in bi-directional learning.
• Precision Medicine
  From essential knowledge on cancer screening updates to clinically impactful biomarker testing and new cancer diagnostic assay development, the ACCC Precision Medicine Library has fundamental resources that match the professional needs and preferred learning styles of the multidisciplinary cancer team.

On-Demand Webinars

• Preanalytics and Tissue Stewardship: Controlling the Molecular Integrity of Patient Samples
  This webinar will review how the steps in the life cycle of a patient specimen can affect its molecular integrity and molecular analysis results.
• Biomarkers in Hematologic Malignancies: A Focus on CLL and Multiple Myeloma
  Two thought leaders who have deep knowledge of—and experience in—biomarker testing in patients with hematologic malignancies will discuss best practices for biomarker testing in chronic lymphocytic leukemia (CLL) and multiple myeloma based on patient case discussions and the latest guidelines.
  

Podcasts

• Liquid Biopsy: Cancer Detection & Future Synergies
• The Promise of MRD Testing in Multiple Myeloma & CLL

Publications

• Bringing CAR T-Cell Therapies to Community Oncology
  
• Bispecific Antibodies Checklist for Community Providers

Digital Tools

• Biomarker Resource Library
  Search this resource bank of nationally available materials relevant to cancer biomarkers and biomarker testing. You may filter by cancer type, area of application, and/or primary audience.
• MRD Testing Implementation Roadmap
  An innovative learning tool that can help multidisciplinary cancer care teams obtain the knowledge they need to implement, expand, and sustain MRD testing for patients with adult B-cell ALL.